Moxifloxacin Hydrochloride Tablets, 400 mg
Moxifloxacin Hydrochloride Tablets, 400 mg is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Moxifloxacin Hydrochloride Tablets, 400 mg; Generic name: MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG; Manufacturer: Novadoz Pharmaceuticals LLC.
| Brand name | Moxifloxacin Hydrochloride Tablets, 400 mg |
|---|---|
| Generic name | MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG |
| Manufacturer | Novadoz Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1.1 ) Skin and Skin Structure Infections: Uncomplicated ( 1.2 ) and Complicated ( 1.3 ) Complicated Intra-Abdominal Infections ( 1.4 ) Plague ( 1.5 ) Acute Bacterial Sinusitis ( 1.6 ) Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin hydrochloride and other antibacterial drugs. Moxifloxacin hydrochloride should be used only to treat |
| Dosage | 2 DOSAGE AND ADMINISTRATION Type of Infection Dose Every 24 hours Duration (days) Community Acquired Pneumonia ( 1.1 ) 400 mg 7 to 14 Uncomplicated Skin and Skin Structure Infections (SSSI) ( 1.2 ) 400 mg 7 Complicated SSSI ( 1.3 ) 400 mg 7 to 21 Complicated Intra-Abdominal Infections ( 1.4 ) 400 mg 5 to 14 Plague ( 1.5 ) 400 mg 10 to 14 Acute Bacterial Sinusitis ( 1.6 ) 400 mg 10 Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7 ) 400 mg 5 No dosage adjustment in patients with renal or h |
| Warnings | WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS Fluoroquinolones, including moxifloxacin hydrochloride, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together [See warnings and Precautions (5.1) ], including: Tendinitis and tendon rupture [See warnings and Precautions (5.2)] Peripheral Neuropathy [See warnings and Pre |
| Active ingredient(s) | MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04e0936f-2248-48e4-8031-ac6ccc2df294 |